Parvovirus B19 RT- PCR, Amniotic Fluid PARVOPCRAM

Synonyms

Allscripts (AEHR) Order Name

Parvovirus B19 PCR, AF

Sunrise Clinical Manager (SCM) Order Name

Parvovirus B19 PCR, AF

Clinical Info

Parvovirus B19 manifests itself as an acute or chronic hematological disorde
r in immunocompromised patients. It can cause persistent anemia, sometimes
associated with leukopenia and thrombocytopenia. Pediatric transplant patients
are at risk for chronic infections, which can be associated with lung and/or renal
disorders. Quantitative DNA PCR can be used to detect the presence of the
virus, track the course of infection, and monitor response to treatment.

Specimen Type

Container

Sterile

Collection Instructions

Container/Tube;: Sterile Screw Top Tubes
Specimen: 2 mL amniotic Fluid (0.5 mL min)
Transport Temperature: Room Temperature

Transport Instructions

Specimen Stability

4 Days Room Temperature

Methodology

Real-Time PCR Quantitative

Days Performed

TAT; 2 - 3 Days

Performing Laboratory

Viracor-Eurofins

CPT

87799

PDM

225036

Result Interpretation

See Report

Forms